Here, we present a simple approach using specific culture media that allows the establishment of neuron- and astrocyte-enriched cultures, or neuron-glia cultures from the embryonic cortex, with high yield and reproducibility.
Method Article
Here, we present a simple approach using specific culture media that allows the establishment of neuron- and astrocyte-enriched cultures, or neuron-glia cultures from the embryonic cortex, with high yield and reproducibility.
Ischemic stroke is a clinical condition characterized by hypoperfusion of brain tissue, leading to oxygen and glucose deprivation, and the consequent neuronal loss. Numerous evidence suggests that the interaction between glial and neuronal cells exert beneficial effects after an ischemic event. Therefore, to explore potential protective mechanisms, it is important to develop models that allow studying neuron-glia interactions in an ischemic environment. Herein we present a simple approach to isolate astrocytes and neurons from the rat embryonic cortex, and that by using specific culture media, allows the establishment of neuron- or astrocyte-enriched cultures or neuron-glia cultures with high yield and reproducibility.
To study the crosstalk between astrocytes and neurons, we propose an approach based on a co-culture system in which neurons cultured in coverslips are maintained in contact with a monolayer of astrocytes plated in multiwell plates. The two cultures are maintained apart by small paraffin spheres. This approach allows the independent manipulation and the application of specific treatments to each cell type, which represents an advantage in many studies.
To simulate what occurs during an ischemic stroke, the cultures are subjected to an oxygen and glucose deprivation protocol. This protocol represents a useful tool to study the role of neuron-glia interactions in ischemic stroke.
According to data from the World Health Organization, about 5.5 million people die every year from ischemic stroke1. This condition is characterized by the interruption of blood flow to a certain brain region, resulting in a reversible or irreversible loss in the supply of oxygen and nutrients to the tissue, which alters tissue function and leads to mitochondrial dysfunction, calcium dysregulation, glutamate excitotoxicity, inflammation and cell loss2,3.
Apart from vascular cells, neuronal and glial cells are involved in the pathophysiology of the ischemic stroke4. In particular, astrocytes are essential to the maintenance of neurons and recently were shown to play a critical role in the response to the ischemic lesion5. This type of glial cell performs functions of structural support, defence against oxidative stress, synthesis of neurotransmitters, stabilization of cell-cell communication, among others6. Along with neurons, astrocytes play a direct role in synaptic transmission, regulating the release of molecules such as adenosine triphosphate, gamma-aminobutyric acid and glutamate7. Part of the injury induced by ischemia is caused by the excessive release of glutamate and its accumulation at the synaptic cleft, leading to the overactivation of N-methyl-D-aspartate receptors, activating downstream signalling cascades, ultimately resulting in excitotoxicity8. Since astrocytes are able to remove glutamate from the synaptic cleft and convert it into glutamine, they are crucial in defending against excitotoxicity, thereby exerting a neuroprotective effect on ischemia. These cells also play a role in ischemia-induced neuroinflammation. After the ischemic insult, activated astrocytes undergo morphologic changes (hypertrophy), proliferate, and show an increase in glial fibrillary acidic protein (GFAP) expression. They can become reactive (astrogliosis), releasing pro-inflammatory cytokines such as tumour necrosis factor-α, interleukin-1α and interleukin-1β, and producing free radicals, including nitric oxide and superoxide, which in turn can induce neuronal death9,10. In contrast, reactive astrocytes may also play a neuroprotective effect, since they release anti-inflammatory cytokines, such as transforming growth factor-β, that is upregulated after stroke11. Moreover, they can generate a glial scar, which can limit tissue regeneration by inhibiting axonal sprouting; however, this glial scar can isolate the injury site from viable tissue, thus preventing a cascading wave of uncontrolled tissue damage12,13.
Thus, it is imperative to establish models that allow studying neuron-glia interactions under an ischemic injury in order to find therapeutic strategies that limit or reverse the effects of ischemic injury. Compared to other models used to study ischemic injury, namely in vivo models14,15,16, organotypic cultures17,18,19 and acute brain slices20,21,22, primary cell cultures are less complex, which makes possible the study of individual contributions of each cell type in the pathophysiology of ischemic stroke and how each cell type responds to possible therapeutic targets. Typically, in order to study the interactions between neuron-enriched cultures and astrocyte-enriched cultures, neurons and glial cells of postnatal origin are used23,24, or postnatal glial cells and embryonic neurons25,26. Herein is proposed a simple approach to establish neuron- or astrocyte-enriched cultures and neuron-glia cultures from the same tissue. These primary cells are obtained from rat embryonic cortex, a region frequently affected by stroke27,28. Moreover, the dissociation of the tissue is performed only by a mechanical procedure. Therefore, this protocol allows isolating cells in the same stage of development, in a fast and inexpensive way, and with high performance and reproducibility.
The crosstalk between astrocytes and neurons can be explored using a co-culture system in which neurons cultured in coverslips are maintained in contact with a monolayer of astrocytes seeded in multiwell plates. Small paraffin spheres can be used to ensure the separation of the two cell cultures. This approach allows independent manipulation of each cell type before they are brought into contact. For example, it is possible to silence a specific gene in astrocytes and see how it can influence the neuronal vulnerability or protection against ischemic-induced damage. An established method to induce ischemic-like conditions in vitro is oxygen and glucose deprivation (OGD)3, which consists in replacing the regular atmosphere (95% air and 5% CO2) by an anoxic atmosphere (95% N2 and 5% CO2), associated with the omission of glucose.
The method described is suitable for studying the interactions between neurons and astrocytes in the context of ischemic stroke, in a simple, fast, reproducible and inexpensive way.
Access restricted. Please log in or start a trial to view this content.
All animals used were bred at the CICS-UBI Health Science Research Centre in accordance with the national ethical requirements for animal research and with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Directive 2010/63/EU).
1. Rat embryo cortex primary cell culture
2. Co-culture system
3. Oxygen and glucose deprivation
4. Immunocytochemistry assay
NOTE: Perform the immunocytochemistry assay as previously described5.
5. Statistical analysis
Access restricted. Please log in or start a trial to view this content.
To characterize the cultures, immunocytochemistry to assess the number of cells that expressed GFAP or MAP2, widely used markers of astrocytes and neurons (Figure 2), was performed in each type of cortical culture. This analysis revealed that astrocyte-enriched cultures presented 97% of the cells expressing GFAP (Figure 2A). Regarding the neuron-enriched culture 78% of the cells expressed MAP2, 4% of the cells expressed GFAP, and 18% of the cells were both GFAP ...
Access restricted. Please log in or start a trial to view this content.
The method here described consists of the astrocyte and neuron isolation from rat embryonic cortical tissue, allowing the establishment of neuron- or astrocyte-enriched cultures or neuron-glia cultures. It was adapted from a previous study of our group5, where the cortical neuron–glia and neuron-enriched embryonic cultures isolation were described and the two cultures characterized. Using these cultures, Roque et al. found that astrocytes play a key role in responding to an ischemic damage a...
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no conflict of interests.
The authors acknowledge the funding support by Fundação para a Ciência e a Tecnologia through Projects UIDB/00709/2020, POCI-01-0145-FEDER-029311 and the fellowship SFRH/BD/135936/2018 to JP, by ‘‘Programa Operacional do Centro, Centro 2020” through the project CENTRO-01-0145-FEDER-000013 and funding to the PPBI-Portuguese Platform of BioImaging through the Project POCI-01-0145-FEDER-022122.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 24 -well culture plates | Thermo Fischer Scientific | 142475 | |
| 95% N2/5% CO2 gas cylinder | ArLíquido | ||
| Anti-mouse conjugated to Alexa Fluor 488 | Invitrogen | A11001 | 1/1000 dilution; incubation period - 1 h at room temperature |
| Anti-rabbit conjugated to Alexa Fluor 546 | Invitrogen | A11010 | 1/1000 dilution; incubation period - 1 h at room temperature |
| B27 supplement (50x) | Gibco | 17504-044 | |
| Dako Fluorescence Mounting Medium | Dako | S3023 | |
| D-glucose anhydrous | Fisher Scientific | G/0450/60 | 3.4 g/L |
| Epifluorescence microscope | Zeiss | AxioObserver Z1x | 63x objective |
| Fetal Bovine Serum (FBS) | Biochrom | S0615 | 10% |
| Gentamicin | Sigma-Aldrich | G1272 | 120 µg/mL |
| Glutamate | Sigma-Aldrich | G8415 | 25µM |
| Glutamine | Sigma-Aldrich | G3126 | 0.5 mM |
| Hoechst 33342 | Invitrogen | H1399 | 2 µM; incubation period - 10 min at room temperature |
| Hypoxia incubation chamber | Stemcell Technologies | 27310 | Chamber used for OGD induction |
| Insulin from bovine pancreas | Sigma-Aldrich | I5500 | 5 mg/L |
| Ketamine | Sigma-Aldrich | K-002 | 87.5 mg/Kg |
| Minimum Essential Medium Eagle medium | Sigma-Aldrich | M0268 | warm up to 37 °C before use |
| Mouse Anti-MAP2 | Santa Cruz Biotechnology | Sc-74421 | 1/500 dilution; incubation period overnight at 4 °C |
| Neurobasal medium | Gibco | 21103-049 | warm up to 37 °C before use |
| Paraffin pastilles for histology | Sigma-Aldrich | 1.07164 | Solidification point 56-58°C |
| Paraformaldehyde | Sigma -Aldrich | P6148 | 4% in PBS |
| Penicilin/Streptomycin | Biochrom | A 2213 | penicillin (12U/mL) /streptomycin (12µg/mL) |
| Poly-D-lysine | Sigma-Aldrich | P1024 | |
| Rabbit Anti-GFAP | DAKO | Z0334 | 1/2000 dilution; incubation period overnight at 4 °C |
| Sodium hydrogen carbonate | Fisher Scientific | S/4240/60 | 2.2g/L |
| Xylazine | Sigma-Aldrich | X1126 | 12 mg/Kg |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission